Cargando…
Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review
To evaluate the efficacy and safety of tocilizumab (TCZ) in the treatment of refractory Takayasu arteritis (TAK). Eleven refractory TAK patients treated with TCZ at the First Affiliated Hospital of Anhui Medical University between 2017 July and 2020 December were respectively analyzed. We also respe...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Japan
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986741/ https://www.ncbi.nlm.nih.gov/pubmed/34750666 http://dx.doi.org/10.1007/s00380-021-01981-1 |